|
|
||||||||
The Journal of Immunology, Vol 139, Issue 5 1509-1513, Copyright © 1987 by American Association of Immunologists
ARTICLES |
K Ishibashi, S Hanada and S Hashimoto
Monoclonal antibodies against human T cell leukemia virus type I (HTLV- I) p24 and p19 were produced and employed in the in vivo expression of HTLV-I in some HTLV-I-related subjects by Western blot analysis. The antigenic determinants of these monoclonal antibodies were different from that of natural human anti-HTLV-I antibody examined. Serum p24 was identifiable in almost all of the overt ATL patients (17 of 18, 94%), but not in the chronic ATL cases or HTLV-I carriers. On the other hand, serum p19 was detected in one of the three patients with chronic ATL examined, but not in the overt ATL patients or the HTLV-I carriers. These results indicate that the in vivo expression of HTLV-I p24 and p19 which has reacted with natural anti-HTLV-I antibody can be detected by these monoclonal antibodies. Therefore, the investigation of serum HTLV-I expression may lead to the early detection of overt ATL in an HTLV-I carrier.
This article has been cited by other articles:
![]() |
B. A. Lenzmeier, H. A. Giebler, and J. K. Nyborg Human T-Cell Leukemia Virus Type 1 Tax Requires Direct Access to DNA for Recruitment of CREB Binding Protein to the Viral Promoter Mol. Cell. Biol., February 1, 1998; 18(2): 721 - 731. [Abstract] [Full Text] |
||||
![]() |
A. Brauweiler, P. Garl, A. A. Franklin, H. A. Giebler, and J. K. Nyborg A Molecular Mechanism for Human T-cell Leukemia Virus Latency and Tax Transactivation J. Biol. Chem., May 26, 1995; 270(21): 12814 - 12822. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |